Alnylam Pharma And Inceptive Nucleics Announce $2B Collaboration Agreement With Upfront Consideration Of $30M, Including Cash And Purchase Of Inceptive Equity

뉴스 본문을 불러오고 있어요.

Alnylam Pharma And Inceptive Nucleics Announce $2B Collaboration Agreement With Upfront Consideration Of $30M, Including Cash And Purchase Of Inceptive Equity | 웨이프 WAPE

Alnylam Pharma And Inceptive Nucleics Announce $2B Collaboration Agreement With Upfront Consideration Of $30M, Including Cash And Purchase Of Inceptive Equity

기사 요약

관련 종목

댓글 —